Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort

Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2017-06, Vol.28, p.iii116-iii116
Hauptverfasser: Smith, Denis, Sa-cunha, Antonio, Rouyer, Magali, François, Eric, Monnereau, Alain, Yon, Edwige, Bignon, Emmanuelle, Noize, Pernelle, Droz-Perroteau, Cécile, Moore, Nicholas, Fourrier-réglat, Annie
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page iii116
container_issue
container_start_page iii116
container_title Annals of oncology
container_volume 28
creator Smith, Denis
Sa-cunha, Antonio
Rouyer, Magali
François, Eric
Monnereau, Alain
Yon, Edwige
Bignon, Emmanuelle
Noize, Pernelle
Droz-Perroteau, Cécile
Moore, Nicholas
Fourrier-réglat, Annie
description
doi_str_mv 10.1093/annonc/mdx261.324
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx261_324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419660990</els_id><sourcerecordid>S0923753419660990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2304-89ceb9757800bf078d0d6474aefaa73d3f8d0e61bec8a675076ec744464d3b9e3</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EokvhB3BBc4RDWjt24gRO29UWkCpV2rLnyLEn1CixV7ZTyk_kX-EQ4MhppKf33tjzEfKa0QtGW36pnPNOX07msazZBS_FE7JhVd0WDRXsKdnQtuSFrLg4Iy9i_EYprduyfU7OeMl4JSnbkJ-3c9J-wghKax-MdV8heUjz5AMctnegnIGrw_YapjmpZL2DmOccwTo4ZQFdipACqoQGvtt0DxrT_Ggn1S8WFlMxWoerZcpu8APMLmBEnVQ_IkyY1NJpNWg_-rDoI2jlNAZ4O-0Ou3fv4Xgyvzfk3DzmjUPwE-wP-6vjXU7d-5BekmeDGiO--jPPyfF6_2X3qbi5_fh5t70pdMmpKJpWY9_KSjaU9gOVjaGmFlIoHJSS3PAhK1izHnWjallRWaOWQohaGN63yM8JW3t18DEGHLpTyL8NPzpGuwVLt2LpVixdxpIzb9bMae4nNP8Sfzlkw4fVgPnlDxZDF3U-rUZjl3t0xtv_1P8CqFqkPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Smith, Denis ; Sa-cunha, Antonio ; Rouyer, Magali ; François, Eric ; Monnereau, Alain ; Yon, Edwige ; Bignon, Emmanuelle ; Noize, Pernelle ; Droz-Perroteau, Cécile ; Moore, Nicholas ; Fourrier-réglat, Annie</creator><creatorcontrib>Smith, Denis ; Sa-cunha, Antonio ; Rouyer, Magali ; François, Eric ; Monnereau, Alain ; Yon, Edwige ; Bignon, Emmanuelle ; Noize, Pernelle ; Droz-Perroteau, Cécile ; Moore, Nicholas ; Fourrier-réglat, Annie</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx261.324</identifier><identifier>PMID: 32135701</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-06, Vol.28, p.iii116-iii116</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32135701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Denis</creatorcontrib><creatorcontrib>Sa-cunha, Antonio</creatorcontrib><creatorcontrib>Rouyer, Magali</creatorcontrib><creatorcontrib>François, Eric</creatorcontrib><creatorcontrib>Monnereau, Alain</creatorcontrib><creatorcontrib>Yon, Edwige</creatorcontrib><creatorcontrib>Bignon, Emmanuelle</creatorcontrib><creatorcontrib>Noize, Pernelle</creatorcontrib><creatorcontrib>Droz-Perroteau, Cécile</creatorcontrib><creatorcontrib>Moore, Nicholas</creatorcontrib><creatorcontrib>Fourrier-réglat, Annie</creatorcontrib><title>Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAQhS0EokvhB3BBc4RDWjt24gRO29UWkCpV2rLnyLEn1CixV7ZTyk_kX-EQ4MhppKf33tjzEfKa0QtGW36pnPNOX07msazZBS_FE7JhVd0WDRXsKdnQtuSFrLg4Iy9i_EYprduyfU7OeMl4JSnbkJ-3c9J-wghKax-MdV8heUjz5AMctnegnIGrw_YapjmpZL2DmOccwTo4ZQFdipACqoQGvtt0DxrT_Ggn1S8WFlMxWoerZcpu8APMLmBEnVQ_IkyY1NJpNWg_-rDoI2jlNAZ4O-0Ou3fv4Xgyvzfk3DzmjUPwE-wP-6vjXU7d-5BekmeDGiO--jPPyfF6_2X3qbi5_fh5t70pdMmpKJpWY9_KSjaU9gOVjaGmFlIoHJSS3PAhK1izHnWjallRWaOWQohaGN63yM8JW3t18DEGHLpTyL8NPzpGuwVLt2LpVixdxpIzb9bMae4nNP8Sfzlkw4fVgPnlDxZDF3U-rUZjl3t0xtv_1P8CqFqkPQ</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Smith, Denis</creator><creator>Sa-cunha, Antonio</creator><creator>Rouyer, Magali</creator><creator>François, Eric</creator><creator>Monnereau, Alain</creator><creator>Yon, Edwige</creator><creator>Bignon, Emmanuelle</creator><creator>Noize, Pernelle</creator><creator>Droz-Perroteau, Cécile</creator><creator>Moore, Nicholas</creator><creator>Fourrier-réglat, Annie</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201706</creationdate><title>Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort</title><author>Smith, Denis ; Sa-cunha, Antonio ; Rouyer, Magali ; François, Eric ; Monnereau, Alain ; Yon, Edwige ; Bignon, Emmanuelle ; Noize, Pernelle ; Droz-Perroteau, Cécile ; Moore, Nicholas ; Fourrier-réglat, Annie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2304-89ceb9757800bf078d0d6474aefaa73d3f8d0e61bec8a675076ec744464d3b9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Denis</creatorcontrib><creatorcontrib>Sa-cunha, Antonio</creatorcontrib><creatorcontrib>Rouyer, Magali</creatorcontrib><creatorcontrib>François, Eric</creatorcontrib><creatorcontrib>Monnereau, Alain</creatorcontrib><creatorcontrib>Yon, Edwige</creatorcontrib><creatorcontrib>Bignon, Emmanuelle</creatorcontrib><creatorcontrib>Noize, Pernelle</creatorcontrib><creatorcontrib>Droz-Perroteau, Cécile</creatorcontrib><creatorcontrib>Moore, Nicholas</creatorcontrib><creatorcontrib>Fourrier-réglat, Annie</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Denis</au><au>Sa-cunha, Antonio</au><au>Rouyer, Magali</au><au>François, Eric</au><au>Monnereau, Alain</au><au>Yon, Edwige</au><au>Bignon, Emmanuelle</au><au>Noize, Pernelle</au><au>Droz-Perroteau, Cécile</au><au>Moore, Nicholas</au><au>Fourrier-réglat, Annie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>28</volume><spage>iii116</spage><epage>iii116</epage><pages>iii116-iii116</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32135701</pmid><doi>10.1093/annonc/mdx261.324</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2017-06, Vol.28, p.iii116-iii116
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdx261_324
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T04%3A51%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20according%20to%20tumor%20RAS%20and%20BRAF%20mutation%20status%20in%20patients%20treated%20with%20cetuximab%20in%201st-line%20treatment%20of%20unresectable%20metastatic%20colorectal%20cancer%20(mCRC):%20Updated%20results%20from%20EREBUS%20cohort&rft.jtitle=Annals%20of%20oncology&rft.au=Smith,%20Denis&rft.date=2017-06&rft.volume=28&rft.spage=iii116&rft.epage=iii116&rft.pages=iii116-iii116&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx261.324&rft_dat=%3Celsevier_cross%3ES0923753419660990%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32135701&rft_els_id=S0923753419660990&rfr_iscdi=true